Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 3
1(100.0%)
1Total
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT01173146Withdrawn

Imaging of Residual Tumor During Prostatectomy

Role: lead

NCT01173133Unknown

Skin Flap Visible Light Spectroscopy (VLS) Oximetry for Monitoring Free-Flap Ischemia During Breast Reconstruction and Recovery

Role: lead

NCT01287559Unknown

Monitoring Necrotizing Enterocolitis in Premature Infants

Role: lead

NCT00671385Unknown

Survey of Optical Values of the Breast Using Radiation-Free Pressure-Free Optical Scanning

Role: lead

NCT00671203Phase 3Completed

Prevention of Colon Ischemia During Aortic Aneurysm (AAA) Repair

Role: lead

All 5 trials loaded